This AI Model Could Keep Thousands Of Cancer Patients From Getting Unnecessary Treatments
Ataraxis has developed an AI test to precisely differentiate between high-risk and low-risk breast cancer, potentially reducing unnecessary chemotherapy treatments.
Valar Labs debuts AI-powered cancer care prediction tool and secures $22M | TechCrunch
AI in healthcare, like Valar Labs' Vesta tool, aims to predict treatment outcomes accurately, saving time for patients with specific cancers.
Aignostics secures 31M from ATHOS, HTGF, others - Silicon Canals
Aignostics raised $34M to enhance AI capabilities in pathology, targeting improvements in diagnostics and collaborations with major healthcare institutions.
This AI Model Could Keep Thousands Of Cancer Patients From Getting Unnecessary Treatments
Ataraxis has developed an AI test to precisely differentiate between high-risk and low-risk breast cancer, potentially reducing unnecessary chemotherapy treatments.
Valar Labs debuts AI-powered cancer care prediction tool and secures $22M | TechCrunch
AI in healthcare, like Valar Labs' Vesta tool, aims to predict treatment outcomes accurately, saving time for patients with specific cancers.
Aignostics secures 31M from ATHOS, HTGF, others - Silicon Canals
Aignostics raised $34M to enhance AI capabilities in pathology, targeting improvements in diagnostics and collaborations with major healthcare institutions.
German healthtech startup Lucid Genomics secures 1.3M
Lucid Genomics has raised €1.3M to enhance their AI-driven platform for comprehensive genetic insight, targeting improvements in drug discovery and disease diagnostics.
Phenomix Sciences Raises $7.8M in Funding to Accelerate Adoption of Obesity Precision Medicine
Phenomix Sciences secured $7.8 million funding for precision medicine in obesity to accelerate commercialization and adoption of MyPhenome test.
German healthtech startup Lucid Genomics secures 1.3M
Lucid Genomics has raised €1.3M to enhance their AI-driven platform for comprehensive genetic insight, targeting improvements in drug discovery and disease diagnostics.
Phenomix Sciences Raises $7.8M in Funding to Accelerate Adoption of Obesity Precision Medicine
Phenomix Sciences secured $7.8 million funding for precision medicine in obesity to accelerate commercialization and adoption of MyPhenome test.
Investigators Discover New Therapeutic Target for Pediatric Brain Cancers - News Center
Targeting TIM3 protein may enhance survival in pediatric brain cancer treatments, specifically low-grade astrocytoma, presenting a potential new therapeutic option.
Does your brain reflect your sex? - Harvard Gazette
Precision medicine is just one field where the answer matters
How precision medicine is tackling stubborn cancers in 2024
Cancer cases and deaths are projected to increase significantly by 2040 despite advancements in treatment.
Precision medicine offers personalized cancer treatment by targeting specific mutations, maximizing effectiveness, and minimizing side effects.
NIMH Research and Science Track at 2024 APA Annual Meeting
National Institute of Mental Health (NIMH) hosts the Research and Science track at the 2024 APA Annual Meeting, focusing on addiction and mental health research.
Metabolon Secures $60M Credit Facility to Accelerate Growth Initiatives
Metabolon secured $60M credit facility from Trinity Capital, enabling growth in R&D, global expansion for metabolomics solutions in life sciences.
Precision Medicine Has a Data Equity Problem - Non Profit News | Nonprofit Quarterly
Precision medicine has the potential to rectify healthcare inefficiencies and disparities, but current disparities in genomic data may perpetuate inequality.
Precision medicine has led to improved treatments for rare diseases, advancements in cancer care, and revolutionized prenatal genetic testing.
Researchers are figuring out how African ancestry can affect certain brain disorders
Genomic studies lacked data on Black Americans' neurological disorders, leading to the creation of the African Ancestry Neuroscience Research Initiative in Baltimore.
NHS gene check is helping children with cancer
Whole genome sequencing (WGS) improves children's cancer treatment by identifying cancer-causing mutations, guiding precise medicine selection, and assessing familial cancer risks.
From data to drugs: How AI is revolutionising drug development
AI is transforming drug discovery through automation and precision, moving from artisanal to data-driven processes.